224 related articles for article (PubMed ID: 3306455)
1. Iatrogenic Creutzfeldt-Jakob disease.
Rappaport EB
Neurology; 1987 Sep; 37(9):1520-2. PubMed ID: 3306455
[TBL] [Abstract][Full Text] [Related]
2. Iatrogenic Creutzfeldt-Jakob disease.
Kobayashi A; Kitamoto T; Mizusawa H
Handb Clin Neurol; 2018; 153():207-218. PubMed ID: 29887137
[TBL] [Abstract][Full Text] [Related]
3. [Iatrogenic Creutzfeldt-Jakob disease. Lessons from cases secondary to extracted growth hormone in France].
Billette de Villemeur T; Pradel A
Transfus Clin Biol; 1994; 1(5):333-7. PubMed ID: 7812459
[TBL] [Abstract][Full Text] [Related]
4. Managing the risk of iatrogenic transmission of Creutzfeldt-Jakob disease in the UK.
Hall V; Brookes D; Nacul L; Gill ON; Connor N;
J Hosp Infect; 2014 Sep; 88(1):22-7. PubMed ID: 25082752
[TBL] [Abstract][Full Text] [Related]
5. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era.
Brown P; Brandel JP; Preece M; Sato T
Neurology; 2006 Aug; 67(3):389-93. PubMed ID: 16855204
[TBL] [Abstract][Full Text] [Related]
6. A statistical model to identify the contaminated lots implicated in iatrogenic transmission of Creutzfeldt-Jakob disease among French human growth hormone recipients.
Huillard d'Aignaux J; Alpérovitch A; Maccario J
Am J Epidemiol; 1998 Mar; 147(6):597-604. PubMed ID: 9521187
[TBL] [Abstract][Full Text] [Related]
7. Creutzfeldt-Jakob disease risk in Slovak recipients of human pituitary growth hormone.
Mitrova E; Belay G
Bratisl Lek Listy; 1999 Apr; 100(4):187-91. PubMed ID: 10914140
[TBL] [Abstract][Full Text] [Related]
8. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
[TBL] [Abstract][Full Text] [Related]
9. [Infectious prion disease: CJD with dura mater transplantation].
Sato T
Rinsho Shinkeigaku; 2003 Nov; 43(11):870-2. PubMed ID: 15152489
[TBL] [Abstract][Full Text] [Related]
10. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts -- Japan, January 1979-May 1996.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(45):1066-9. PubMed ID: 9385874
[TBL] [Abstract][Full Text] [Related]
11. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
Collinge J; Palmer MS; Dryden AJ
Lancet; 1991 Jun; 337(8755):1441-2. PubMed ID: 1675319
[TBL] [Abstract][Full Text] [Related]
12. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease.
Deslys JP; Marcé D; Dormont D
J Gen Virol; 1994 Jan; 75 ( Pt 1)():23-7. PubMed ID: 8113733
[TBL] [Abstract][Full Text] [Related]
13. Iatrogenic Creutzfeldt-Jakob disease, final assessment.
Brown P; Brandel JP; Sato T; Nakamura Y; MacKenzie J; Will RG; Ladogana A; Pocchiari M; Leschek EW; Schonberger LB
Emerg Infect Dis; 2012 Jun; 18(6):901-7. PubMed ID: 22607808
[TBL] [Abstract][Full Text] [Related]
14. Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients?
Boyd A; Klug GM; Schonberger LB; McGlade A; Brandel JP; Masters CL; Collins SJ
Med J Aust; 2010 Sep; 193(6):366-9. PubMed ID: 20854243
[TBL] [Abstract][Full Text] [Related]
15. Human growth hormone and Creutzfeldt-Jakob disease.
Zekauskas S; Boggs MB; Wilson DP
J Okla State Med Assoc; 1990 Sep; 83(9):447-8. PubMed ID: 2280278
[TBL] [Abstract][Full Text] [Related]
16. Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone.
Purro SA; Farrow MA; Linehan J; Nazari T; Thomas DX; Chen Z; Mengel D; Saito T; Saido T; Rudge P; Brandner S; Walsh DM; Collinge J
Nature; 2018 Dec; 564(7736):415-419. PubMed ID: 30546139
[TBL] [Abstract][Full Text] [Related]
17. Creutzfeldt-Jakob disease after receipt of a previously unimplicated brand of dura mater graft.
Hannah EL; Belay ED; Gambetti P; Krause G; Parchi P; Capellari S; Hoffman RE; Schonberger LB
Neurology; 2001 Apr; 56(8):1080-3. PubMed ID: 11320182
[TBL] [Abstract][Full Text] [Related]
18. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
Brandel JP; Peckeu L; Haïk S
Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
[TBL] [Abstract][Full Text] [Related]
19. Tissue safety in view of CJD and variant CJD.
Pauli G
Cell Tissue Bank; 2005; 6(3):191-200. PubMed ID: 16151959
[TBL] [Abstract][Full Text] [Related]
20. Creutzfeldt-Jakob disease in a recipient of a dura mater graft processed in the US: cause or coincidence?
Dobbins JG; Belay ED; Malecki J; Buck BE; Bell M; Cobb J; Schonberger LB
Neuroepidemiology; 2000; 19(2):62-6. PubMed ID: 10686530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
